Current Opinion in Cardiology

Article	Citations
Racial and ethnic disparities in heart failure: current state and future directions	56
Impact of social determinants of health on cardiovascular disease prevention	48
Hypertension and race/ethnicity	43
Modes of bioprosthetic valve failure: a narrative review	35
Measuring LDL-cholesterol: what is the best way to do it?	35
Hypertension and diabetes mellitus: highlights of a complex relationship	30
Gut microbiome and cardiovascular disease	29
Functional characterization of long noncoding RNAs	27
Hypertension in obesity	25
Genetics of hypertriglyceridemia and atherosclerosis	25
COVID-19 myocarditis and long-term heart failure sequelae	23
Artificial intelligence and machine learning in aortic disease	23
Genetics of dilated cardiomyopathy	21
Recent trends in acute myocardial infarction among the young	21
COVID-19 will forever change the landscape of telemedicine	20
Nutrition and physical activity recommendations from the United States and European cardiovascular guidelines: a comparative review	19
Surgical management of mitral annular calcification	18
Triglycerides and cardiovascular disease	17
Artificial intelligence in pediatric cardiology: taking baby steps in the big world of data	17
Hyperkalemia in heart failure	16
Hypertension in children	15
Endocan: a new marker of endothelial function	15
Artificial intelligence in cardiovascular medicine	15
Health anxiety among adults with congenital heart disease	15
Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes	15

The placenta as the window to congenital heart disease	14
Statin intolerance: new data and further options for treatment	13
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy	13
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure	13
Pulmonary hypertension associated with left-sided heart failure	13
The aberrant subclavian artery: approach to management	13
Mobile health in preventive cardiology: current status and future perspective	12
Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology	12
Current management of the vascular subtype of Ehlers–Danlos syndrome	12
RNA therapeutics for cardiovascular disease	11
Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?	11
Racial differences in outcomes after receiving advanced heart failure therapies	11
Speckle tracking echocardiography: imaging insights into the aorta	11
Emergent expansion of clinical epigenetics in patients with cardiovascular diseases	10
The brave new world of genetic testing in the management of the dyslipidaemias	10
Genetics of atrial fibrillation	10
Epidemiology and risk factors for stroke in young individuals: implications for prevention	10
Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers	10
RNA-based therapeutics in cardiovascular disease	10
Cybersecurity threats to cardiac implantable devices: room for improvement	10
Generalizability of Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial in patients with a history of coronary artery bypass graft surgery	10
Molecular genetics of human hypertension	10
Pulsed field ablation: a promise that came true	9
Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease	9
Management of ventricular arrhythmias in patients with LVAD	9
Disparities in acute decompensated heart failure	9
End-of-life care in patients with advanced heart failure	9
Machine learning: at the heart of failure diagnosis	9
Mitral valve surgery for rheumatic heart disease: replace, repair, retrain?	9
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?	9
Global longitudinal strain is a better metric than left ventricular ejection fraction: lessons learned from cancer therapeutic-related cardiac dysfunction	9
Two-year outcomes from the PARTNER 3 trial: where do we stand?	9
Every child with congenital heart disease should be exercising	8
Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events	8
The evolving role of coronary artery calcium in preventive cardiology 30 years after the Agatston score	8
Update on pediatric pulmonary arterial hypertension	8
Clinical trials of acute mechanical circulatory support in cardiogenic shock and high-risk percutaneous coronary intervention	8
Arrhythmogenic right ventricular cardiomyopathy in the pediatric population	8
The impact of socioeconomic status and race on the outcomes of congenital heart disease	8
Atrial arrhythmias in patients with left ventricular assist devices	8
The emerging role of cardiac contractility modulation in heart failure treatment	7
Multimodality cardiac imaging and new display options to broaden our understanding of the tricuspid valve	7
Cardiac rehabilitation for coronary artery disease: latest updates	7
Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease	7
Sodium-glucose cotransporter 2 inhibitors and type 2 diabetes: clinical pearls for in-hospital initiation, in-hospital management, and postdischarge	7
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?	7
Temporary mechanical circulatory support devices: updates from recent studies	7
Transcatheter mitral valve replacement: an update	7
Pulmonary hypertension in heart failure	7
A tale of two balloons: technical and procedural difference between cryoballoon systems	7

Transcatheter mitral valve repair and replacement: the next frontier of transcatheter valve intervention	7
New findings bearing on the prevention, detection and management of high blood pressure	6
Arrhythmias and sudden cardiac death in post-cardiac transplant patients	6
Ischaemia without obstructive coronary artery disease: the pathophysiology of microvascular dysfunction	6
Global interventions in hypertension: new and emerging concepts	6
Percutaneous left atrial appendage occlusion	6
The landscape of cardiogenic shock: epidemiology and current definitions	6
Challenges in diagnosis and management of coarctation of the aorta	6
Medical management of resistant hypertension: the role of sodium-glucose cotransporter 2 inhibitors (SGLT2i)	6
Pharmacologic therapy for pulmonary artery hypertension	6
Cardiovascular disease prevention in individuals with underlying chronic inflammatory disease	6
The cardiac surgeon's guide to artificial intelligence	6
The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors	6
Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons	6
Opportunities for improved cardiovascular disease prevention in oncology patients	6
Epigenetic remodeling in heart failure with preserved ejection fraction	6
Mobile health technologies in the diagnosis and management of atrial fibrillation	6
Myocardial infarction with nonobstructive coronary artery disease (MINOCA): a review of pathophysiology and management	6
N-3 polyunsaturated fatty acids for cardiovascular risk	6
Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management	6
A comparison of surgical, total percutaneous, and hybrid approaches to treatment of combined coronary artery and valvular heart disease	5
Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials	5
Choosing the best antithrombotic regimen in patients with ventricular assist devices	5
Secondary prevention after CABG: do new agents change the paradigm?	5
Regionalization of congenital cardiac surgical care: what it will take	5
The shock team: a multidisciplinary approach to early patient phenotyping and appropriate care escalation in cardiogenic shock	5
Are the current evaluation tools for advanced therapies biased?	5
Coronary artery disease in patients with cancer: challenges and opportunities for improvement	5
Update on cardiovascular risk in nonalcoholic fatty liver disease	5
Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes	5
Bicuspid aortic valve associated aortopathy: 2022 guideline update	5
Representation of Black patients in heart failure clinical trials	5
Cardiovascular effects of preeclampsia	5
Percutaneous management of coronary bifurcation lesions: current perspective	5
Resurgence of the edge-to-edge repair of the mitral valve	4
The genetics of left ventricular noncompaction	4
Clinical trials of cell therapy for heart failure: recent results warrant continued research	4
Adverse events beyond 1 year after percutaneous coronary intervention	4
Storage solutions to improve grafts preservation and longevity in coronary artery bypass grafting surgery: hype or hope?	4
Is the world ready for the STICH 3.0 trial?	4
Culture, teamwork and engagement: 40 years of finding the right ingredients	4
New aspects in the management of hypertension in the digital era	4
Supporting the Ross procedure: preserving root physiology while mitigating autograft dilatation	4
The current landscape of lipoprotein(a) in calcific aortic valvular disease	4
Temporal improvements in perioperative stroke rates following coronary artery bypass grafting	4
Peripheral arterial disease and hypertension	4
Genetics of sudden cardiac death	4
Advances in contemporary medical management to treat patients with heart failure	4
Management of renovascular hypertension	4
Iron deficiency in heart failure: getting to the guidelines	4
Imaging of the mitral valve: role of echocardiography, cardiac magnetic resonance, and cardiac computed tomography	4
Hybrid coronary revascularization: are we there yet?	4
Coronary artery bypass grafting in low ejection fraction: state of the art	4
Chronic thromboembolic pulmonary hypertension anno 2021	4
Review – current opinion in cardiology hypertension in chronic kidney disease	4
Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents	4
Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions	4
Hypertension in cardiac transplant recipients: tackling a new face of an old foe	4
Multifocal arterial disease: clinical implications and management	4
Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down	4
Sleep apnea and cardiovascular risk	4
Consumer wearable technologies to identify and monitor exercise-related arrhythmias in athletes	4
Stress cardiac MRI in stable coronary artery disease	4
Penetrating atherosclerotic ulcer	4
The role of temporary mechanical circulatory support as a bridge to advanced heart failure therapies or recovery	3
Preoperative optimization and rapid discharge after coronary artery bypass grafting	3
Review new concepts in pharmacotherapy for peripheral arterial disease	3
The role of multimodality imaging in patients with heart failure with reduced and preserved ejection fraction	3
Update on the molecular landscape of thoracic aortic aneurysmal disease	3
Valve sparing root replacement: an update	3
Sodium–glucose cotransporter 2 inhibitors at the intersection of cardiovascular, renal and metabolic care: an integrated and multidisciplinary approach to patient-centered care	3
Review of transapical off-pump mitral valve intervention with NeoChord implantation	3
Current evidence on the safety and efficacy of combined atrial fibrillation ablation and left atrial appendage closure	3
The use of multidisciplinary teams, electronic health records tools, and technology to optimize heart failure population health	3
Mechanisms of myocardial infarction with nonobstructive coronary atherosclerosis: a multifaceted play of different actors with guarded prognosis	3
Keeping pace with the competition: His bundle versus biventricular pacing in heart failure	3
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	3
Cardiovascular consequences of vaping	3
Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapies	3
The risk and prevention of sudden death in patients with heart failure with reduced ejection fraction	3

Semaglutide for weight loss and cardiometabolic risk reduction in overweight/obesity	3
Gender differences in acute aortic syndromes	3
Adverse pregnancy outcomes and future risk of heart failure	3
Surgical treatment of mitral regurgitation	3
Diet and vascular risk	3
Economics and laboratory efficiency of atrial fibrillation ablation	3
Calmodulinopathies: throwing back the veil on the newest life-threatening genetic arrhythmia syndrome	3
Current and future transcatheter aortic valve replacement valves	3
Revascularization strategies for left main coronary artery disease: current perspectives	3
Omega-3 fatty acid therapy for cardiovascular disease: justified or not?	3
Personalized external aortic root support in aneurysm disease	3
Transcatheter treatment of severe tricuspid regurgitation	3
Patient-specific preprocedural planning for tricuspid valve repair and replacement procedures	3
The role of icosapent ethyl in cardiovascular risk reduction	3
Hypertension and heart failure: focus on high-risk populations	2
Skeletal muscle (dys)function in heart failure with preserved ejection fraction	2
Impact of ultrasound enhancing agents on clinical management	2
RNA interference-based therapies for the control of atherosclerosis risk factors	2
Unanswered questions on coronary artery graft patency and clinical outcomes	2
Peripartum cardiomyopathy: risk factors and predictors of outcome	2
Antithrombotic therapy after transcatheter aortic valve replacement: current perspective	2
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	2
Assessment and management of coronary artery disease in patients undergoing transcatheter aortic valve replacement	2
Pulmonary arterial hypertension in pregnancy	2
Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approa	2
Less invasive multivessel coronary artery bypass grafting: now is the time	2
Is there a problem with respect? Risk of neochordal rupture	2
Surgical options for aortic root aneurysm disease: which procedure, which patient	2
Engaging medical students in cardiac surgery: a focus on equity, diversity, and inclusion	2
Novel devices for managing heart failure	2
Degenerative mitral regurgitation	2
Newer risk assessment strategies in hypertrophic cardiomyopathy	2
The influence of age and sex on the prognostic importance of traditional cardiovascular risk factors, selected circulating biomarkers and other markers of subclinical cardiovascular damage	2
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	2
Functional mitral regurgitation	2
Building new cardiac vasculature and myocardium: where are we at?	2
Hypertension and cognitive function: a review of life-course factors and disparities	2
Catheter-based therapies in acute and chronic pulmonary embolism	2
Long noncoding RNAs in cardiovascular disease	2
Factor XI inhibitors: what should clinicians know	2
Ambulatory advanced heart failure patients: timing of mechanical circulatory support – delaying the inevitable?	2
Percutaneous management of calcified coronary arteries – review of atherectomy and lithotripsy devices and why it is important	2
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	2
Surgical treatment of severe tricuspid regurgitation	2
Hypertension in the elderly: recent developments and insights	2
Selection of percutaneous mechanical circulatory support in cardiogenic shock: patient-specific considerations and insights from contemporary clinical data	2
When is enough, enough? Exploring ethical and team considerations in paediatric cardiac care dilemmas	2
Destination LVAD therapy in the current era of the heart transplant allocation system	2
The role of skeletal muscle mass on cardiovascular disease risk: an emerging role on modulating lipid profile	2
Genetics of atrial fibrillation	2
The systemic right ventricle in adult congenital heart disease: why is it still such a challenge and is there any hope on the horizon?	2
Combined transcatheter mitral and tricuspid edge-to-edge repair: expanding the horizons of interventional heart failure	2
Surgical repair of ischemic mitral regurgitation: one ring does not fit all	2
Coronary artery calcium testing in young adults	2
Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine	2
Atrial functional mitral regurgitation	2
Targeting multiple domains of residual cardiovascular disease risk in patients with diabetes	2
Ventricular arrhythmias in heart failure with reduced ejection fraction	2
Distinct pathological mechanisms distinguish acute coronary syndrome caused by plaque erosion from plaque rupture	2
Brugada syndrome – minimizing overdiagnosis and over treatment in children	2
Genetics of aortic valve disease	2